LIN
Linde Plc
NASDAQ · Basic Materials · Chemicals - Specialty · GB
$500.57
−0.26%Year over year
Reported trailing growth
- Revenue
- +6.6%
- EBITDA
- +4.9%
- EBIT
- +7.5%
- EPS
- +10.2%
- Free cash flow
- -1.9%
- Operating cash flow
- +5.8%
Forward estimates
Based on analyst estimates
- Revenue
- +6.4%
- EBITDA
- +19.9%
- EPS
- +23.0%
Three-year CAGR
- Revenue
- +0.6%
- EBITDA
- +6.9%
- EBIT
- +12.7%
- Net income
- +18.5%
- EPS
- +20.9%
- Free cash flow
- -3.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026